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The chronic pain sufferer is currently faced with a lack of objective tools to identify
the source of their pain. The overarching goal is to develop clinical [18F]FDG PET/
MRI methods to more accurately localize sites of increased neuronal and muscular
metabolism or inflammation as it relates to neurogenic sources of pain and to ulti-
mately improve outcomes of chronic pain sufferers. The aims are to 1) correlate ima-
ging findings with location of pain symptomology, 2) predict location of symptoms
based on imaging findings alone and 3) to determine whether the imaging results affect
current management decisions. Six patients suffering from chronic lower extremity
neuropathic pain (4 complex regional pain syndrome, 1 chronic sciatica and 1 neuro-
pathic pain) have been imaged with a PET/MRI system (time-of-flight PET; 3.0T bore)
from mid thorax through the feet. All patients underwent PET/MR imaging one hour
after a injection of 10mCi [18F]FDG. Two radiologists evaluated PET/MR images (one
blinded and the other unblinded to patient exam/history). ROI analysis showed focal
increased [18F]FDG uptake in affected nerves and muscle (approx 2-4 times more)
over background tissue in various regions of the body in 5 of 6 patients at the site of
greatest pain symptoms and other areas of the body (SUVmax of Target 0.9-4.2 vs.
Background 0.2-1.2). The radiologist blind to the patient history/exam was able to cor-
rectly identify side/location of the symptoms in 5 out of 6 patients. Imaging results
were reviewed with the referring physician, who then determined whether a modifica-
tion in the management plan was needed: 1/6 no change, 2/6 mild modification (e.g.,
additional diagnostic test ordered) and 3/6 significant modification.
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